Medicare Enrolled

Dr. Farrukh Zaidi, MD

Rheumatology · Port Richey, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8029 WASHINGTON ST, Port Richey, FL 34668
3525964080
In practice since 2006 (19 years)
NPI: 1346292414 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zaidi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zaidi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zaidi

Dr. Farrukh Zaidi is a rheumatology specialist in Port Richey, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zaidi performed 27,039 Medicare services across 1,062 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zaidi received a total of $5,641 from 22 pharmaceutical and/or device companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zaidi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in FL $5,641 industry payments

Medicare Practice Summary

Medicare Utilization ↗
27,039
Medicare services
Top 42% in FL for rheumatology
1,062
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,423 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
11,225 $34 $90
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
7,300 $11 $48
Denosumab injection (Prolia/Xgeva) 4,440 $18 $40
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,173 $26 $127
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
712 $90 $207
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
268 $99 $289
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
122 $22 $62
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
121 $9 $18
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
117 $55 $145
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $62 $140
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
94 $116 $324
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
93 $11 $50
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
81 $78 $187
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
57 $131 $279
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
51 $49 $157
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
29 $33 $85
Injection, methylprednisolone acetate, 40 mg 21 $5 $7
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
17 $82 $210
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
15 $46 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
77.5% high complexity
18.7% medium
3.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,641
Total received (2018-2024)
Avg $806/year across 7 years
Bottom 45% in FL for rheumatology
22
Companies
207
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,269 (75.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,353 (24.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$130
2023
$656
2022
$1,997
2021
$567
2020
$630
2019
$1,114
2018
$547

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,638
UCB, Inc.
$1,394
GlaxoSmithKline, LLC.
$653
Lilly USA, LLC
$515
Novartis Pharmaceuticals Corporation
$256
AbbVie Inc.
$211
Genentech USA, Inc.
$171
Janssen Biotech, Inc.
$151
GENZYME CORPORATION
$148
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
ABBVIE INC.
$69
Radius Health, Inc.
$51
Aurinia Pharma U.S., Inc.
$45
PFIZER INC.
$42
E.R. Squibb & Sons, L.L.C.
$32
Bioventus LLC
$26
Organon Llc
$26
AbbVie, Inc.
$21
SOBI, INC
$19
Horizon Therapeutics plc
$17
Merck Sharp & Dohme Corporation
$15
Avion Pharmaceuticals
$15
Top 3 companies account for 65.3% of total payments
Associated products mentioned in payments ›
AMJEVITA · ANORO · Actemra · BENLYSTA · Balcoltra · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · GELSYN-3 · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · NUCALA · ORENCIA · Otezla · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SIMPONI · SIMPONI ARIA · SKYRIZI · TALTZ · TRELEGY ELLIPTA · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $21 per 100 Medicare services performed
Looking for a rheumatology specialist in Port Richey?
Compare rheumatologists in the Port Richey area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
31
Per 100K population
5.3
County median income
$67,384
Nearest hospital
MORTON PLANT NORTH BAY HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Zaidi is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Zaidi experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Zaidi performed 11,225 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zaidi receive payments from pharmaceutical companies?
Yes. Dr. Zaidi received a total of $5,641 from 22 companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zaidi's costs compare to other rheumatologists in Port Richey?
Dr. Zaidi's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zaidi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →